Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Fluorescence detection of cervical intraepithelial neoplasia for photodynamic therapy with the topical agents 5-aminolevulinic acid and benzoporphyrin-derivative monoacid ring

Article Abstract:

5-aminolevulinic acid is taken up only by abnormal cervical cells whereas benzoporphyrin-derivative monoacid ring is not. Therefore, 5-aminolevulinic acid would be a more effective photosensitizer for use in the treatment of abnormal cervical cells with phototherapy.

Author: DiSaia, Philip J., Keefe, Kristin A., Chahine, Elizabeth B., Krasieva, Tatiana B., Lin, Fritz, Berns, Michael W., Tadir, Yona
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
Usage, Cervix dysplasia, Phototherapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Structural and functional effects of endometrial photodynamic therapy in a rat model

Article Abstract:

Differing light dosages may produce differing effects on the uterine lining during photodynamic therapy. Photodynamic therapy uses chemicals to sensitize specific tissues to light and then exposes those tissues to laser light to destroy them. It is a promising nonsurgical technique for destroying abnormal growth of the uterine lining. Researchers exposed the uterus of 74 rats to laser light after injecting a light-sensitizing chemical. At one light dosage, connective tissue and muscle were damaged, but the lining recovered within three weeks. At a dosage 1.5 times higher, the lining was permanently destroyed.

Author: Berns, Michael W., Tadir, Yona, Tromberg, Bruce J., Fehr, Mathias K., Svaasand, Lars O., Ngo, Phat
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1996
Photochemotherapy, Endometrial hyperplasia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Selective photosensitizer localization in the human endometrium after intrauterine application of 5-aminolevulinic acid

Article Abstract:

Photodynamic therapy may be used to destroy abnormal endometrial tissue. Photodynamic therapy has been used in place of surgery in animals to destroy tissue with light-induced oxidation. Researchers measured the levels of photosensitizers in the uteri of 27 women undergoing hysterectomy and the length of time after instilling 5-aminolevulinic acid into the uterus before it reached maximum fluorescence. 5-aminolevulinic acid induced sufficient fluorescence in the endometrium to allow photodynamic therapy to be used. Maximum fluorescence was reached four to eight hours after the acid was instilled.

Author: DiSaia, Philip J., Lin, Fritz, Tadir, Yona, Tromberg, Bruce J., Fehr, Mathias K., Krasieva, Tatiana, Wyss, Pius
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1996
Physiological aspects, Endometrium, Photosensitizing compounds, Photosensitizing agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Evaluation
Similar abstracts:
  • Abstracts: The effects of intrapartum magnesium sulfate therapy on fetal serum interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha at delivery: a randomized, placebo-controlled trial
  • Abstracts: Three births after preimplantation genetic diagnosis for cystic fibrosis with sequential first and second polar body analysis
  • Abstracts: Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: morbidity and survival
  • Abstracts: Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
  • Abstracts: The utility of umbilical artery Doppler investigation in women with the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.